DK1981908T3 - Ny FSH-glykosyleringsvariant D3N - Google Patents

Ny FSH-glykosyleringsvariant D3N

Info

Publication number
DK1981908T3
DK1981908T3 DK07716617.1T DK07716617T DK1981908T3 DK 1981908 T3 DK1981908 T3 DK 1981908T3 DK 07716617 T DK07716617 T DK 07716617T DK 1981908 T3 DK1981908 T3 DK 1981908T3
Authority
DK
Denmark
Prior art keywords
glycosylation variant
new
fsh glycosylation
new fsh
variant
Prior art date
Application number
DK07716617.1T
Other languages
English (en)
Inventor
Marco Muda
Xuliang Jiang
Sean D Mckenna
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of DK1981908T3 publication Critical patent/DK1981908T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK07716617.1T 2006-01-17 2007-01-16 Ny FSH-glykosyleringsvariant D3N DK1981908T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75948606P 2006-01-17 2006-01-17
PCT/US2007/001004 WO2007084441A2 (en) 2006-01-17 2007-01-16 Novel fsh glycosylation variant d3n

Publications (1)

Publication Number Publication Date
DK1981908T3 true DK1981908T3 (da) 2010-12-13

Family

ID=38163618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07716617.1T DK1981908T3 (da) 2006-01-17 2007-01-16 Ny FSH-glykosyleringsvariant D3N

Country Status (22)

Country Link
US (1) US7956034B2 (da)
EP (1) EP1981908B1 (da)
JP (1) JP2009523445A (da)
KR (1) KR20080094697A (da)
CN (1) CN101370825B (da)
AR (1) AR059054A1 (da)
AT (1) ATE487738T1 (da)
AU (1) AU2007207697B2 (da)
BR (1) BRPI0706628A2 (da)
CA (1) CA2633844A1 (da)
CY (1) CY1110953T1 (da)
DE (1) DE602007010425D1 (da)
DK (1) DK1981908T3 (da)
EA (1) EA013974B1 (da)
HR (1) HRP20100610T1 (da)
IL (1) IL192547A (da)
PL (1) PL1981908T3 (da)
PT (1) PT1981908E (da)
RS (1) RS51792B (da)
SI (1) SI1981908T1 (da)
WO (1) WO2007084441A2 (da)
ZA (1) ZA200805194B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080219952A1 (en) * 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
JP5199112B2 (ja) * 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Fsh又はfsh変異体を精製するための方法
MY145839A (en) 2005-12-22 2012-04-30 Merck Serono Sa Fsh mutants
EP2203465A1 (en) * 2007-10-22 2010-07-07 Merck Serono S.A. Method for purifying an fc-containing protein
CA2702448A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying fc-fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU747179B2 (en) * 1997-06-25 2002-05-09 Merck Serono Sa Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
IL161541A0 (en) 2001-10-22 2004-09-27 Applied Research Systems Mutant glycoproteins
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
JP5199112B2 (ja) * 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Fsh又はfsh変異体を精製するための方法

Also Published As

Publication number Publication date
CN101370825A (zh) 2009-02-18
DE602007010425D1 (de) 2010-12-23
PT1981908E (pt) 2010-11-23
ATE487738T1 (de) 2010-11-15
AU2007207697A2 (en) 2008-07-31
ZA200805194B (en) 2009-10-28
KR20080094697A (ko) 2008-10-23
PL1981908T3 (pl) 2011-04-29
WO2007084441A2 (en) 2007-07-26
RS51792B (sr) 2011-12-31
IL192547A (en) 2012-04-30
WO2007084441A3 (en) 2007-09-07
EP1981908B1 (en) 2010-11-10
EA200870177A1 (ru) 2009-02-27
CN101370825B (zh) 2012-10-10
HRP20100610T1 (hr) 2010-12-31
EA013974B1 (ru) 2010-08-30
IL192547A0 (en) 2009-02-11
AR059054A1 (es) 2008-03-12
AU2007207697A1 (en) 2007-07-26
JP2009523445A (ja) 2009-06-25
CA2633844A1 (en) 2007-07-26
CY1110953T1 (el) 2015-06-11
BRPI0706628A2 (pt) 2011-04-05
AU2007207697B2 (en) 2012-01-19
EP1981908A2 (en) 2008-10-22
US7956034B2 (en) 2011-06-07
SI1981908T1 (sl) 2011-01-31
US20080280832A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
NL301103I2 (nl) tagraxofusp
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
ES1065656Y (es) Helicoptero
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
DK1849352T3 (da) Mejetærsker
ES2896053T8 (es) Biogel
FR2899996B1 (fr) Disjoncteur.
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
DE602007007460D1 (de) Sehkrafttestsystem
DE502006006067D1 (de) Ng
DE502007001652D1 (de) Notöltank
DE502007005975D1 (de) Wischblatt
DE602006000836D1 (de) Leitungssteuerungsanordnung
ATE487738T1 (de) Neue fsh-glykosilierungsvariante d3n
DE502007003774D1 (de) Werkzeugaufnahme
DE502007001097D1 (de) Lenkeranordnung
PT2062053E (pt) Métodos de imunoensaio melhorados
DE502007002798D1 (de) Breitwebmaschine
DE202005018500U1 (de) Doppel-Universaldimmer
DE112007002197A5 (de) Waschvorrichtung
ES1062478Y (es) Farola
ATE448844T1 (de) Helikopter
ITTO20060734A1 (it) Elicottero
ES1062650Y (es) Sacapuntas con deposito
CN300738776S (zh) 绝缘子